Nepafenac Ophthalmic Suspension, 0.1%

DRUG4 trials

Sponsors

Alcon Research

Conditions

Cataract

Phase 2

Nepafenac 0.3% Two Study

CompletedNCT01318499

Alcon ResearchCataract

Start: 2011-03-31End: 2011-09-30Updated: 2012-12-17

Phase 3

Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery

CompletedNCT00333255

Alcon ResearchCataract

Start: 2005-09-30Updated: 2009-07-08

Confirmatory Study Nepafenac 0.3%

CompletedNCT01109173

Alcon ResearchCataract

Start: 2010-06-30Updated: 2012-11-30

Nepafenac Compared to Placebo for Ocular Pain and Inflammation

CompletedNCT01426854

Alcon ResearchCataract

Start: 2011-07-31End: 2012-04-30Updated: 2013-05-13